Streetbeat News

Products Services

LEGH

MG

MIRM

SNOW

Insider purchases at Snowflake, Legacy Housing, Mistras Group, and Mirum Pharmaceuticals signal confidence in these companies. Snowflake's CEO bought shares worth $5M, despite a recent downgrade. Legacy Housing and Mistras Group saw insider buys after reporting disappointing financial results. Mirum Pharmaceuticals' CFO purchased shares following FDA approval of its drug, Livmarli.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 12:33 pm

RSLS

ReShape Lifesciences has received a notice of allowance for an additional US patent related to its intragastric balloon system. This development could enhance the company's intellectual property portfolio and potentially its market position in obesity management solutions.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:31 pm

INZY

MESO

PNTG

SPRY

STIM

As of March 28, 2024, five health care stocks are considered overbought based on their RSI values, indicating potential short-term declines. These include The Pennant Group, Inc. (PNTG), Mesoblast Limited (MESO), ARS Pharmaceuticals, Inc. (SPRY), Neuronetics, Inc. (STIM), and Inozyme Pharma, Inc. (INZY). Each company has recently reported significant developments or financial results, contributing to rapid stock price increases and high RSI values.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 12:30 pm

VZIO

WMT

Walmart Inc (NYSE:WMT) plans to refile its acquisition documents for Vizio Holding Corp (NYSE:VZIO) after withdrawing its initial filing to allow more time for antitrust review. The over $2 billion deal aims to enhance Walmart's advertising revenue and customer services by leveraging Vizio's expertise in TVs, advertising, and streaming. The refiling follows discussions with the Federal Trade Commission and the Department of Justice, with a new waiting period set to expire on April 29, 2024.

Portfolio Pulse from Shivani Kumaresan

March 28, 2024 | 12:28 pm

WKSP

Worksport Ltd. (NASDAQ:WKSP) has received the necessary custom solar panels to begin production of the SOLIS Solar Tonneau Cover in New York. This marks a significant step towards the product's market launch this summer. The solar panels, boasting high power output and flexibility, are crucial for the innovative cover designed for pickup trucks. Worksport is also preparing to introduce the COR Battery System, complementing the solar cover. CEO Steven Rossi highlights this development as a testament to the team's dedication, aiming to impact the automotive and renewable energy sectors positively.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:12 pm

BWAY

BrainsWay announced the publication of post-marketing analysis results on late-life depression in the Journal of Clinical Medicine. The study likely showcases the effectiveness of BrainsWay's technology in treating this condition, which could influence the company's reputation and potentially its financial performance.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:10 pm

CMPS

Compass Pathways co-founders George Goldsmith and Ekaterina Malievskaia have resigned from the board, effective March 29, 2024. David Norton will serve as interim chair while the company searches for a permanent replacement. The company highlights its progress in developing psilocybin treatment for treatment-resistant depression and its achievements under the leadership of Goldsmith and Malievskaia, including FDA Breakthrough Therapy Designation and successful financing rounds.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:09 pm

AGFY

Agrify Corporation (NASDAQ:AGFY) has signed a contract with Connecticut-based New England Edibles, dba SoundView, to provide a Turnkey Hydrocarbon Extraction and Lab Equipment Package. This package includes various extraction systems and services to assist SoundView in meeting compliance for operation in Connecticut. SoundView, a woman and veteran-owned startup, aims to process and manufacture cannabis products for the CT market. Agrify's support encompasses design, equipment, and training, facilitating SoundView's setup for extraction capabilities.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:08 pm

RVPH

Reviva Pharmaceuticals Holdings, Inc. (RVPH) is set to present the Phase 3 clinical trial data for Brilaroxazine, its treatment for schizophrenia, at the SIRS 2024 Annual Meeting on April 4. This marks a significant milestone in the development of Brilaroxazine and could have implications for its future commercial potential.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:07 pm

LPCN

Lipocine Inc. announced positive week 52 results from its LPCN 1148 Phase 2 study in patients with cirrhosis, meeting both primary and hepatic encephalopathy endpoints. This marks a significant milestone in the development of LPCN 1148 for treating cirrhosis.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:02 pm